Michael Alfieri
Principal Financial Officer · Aldeyra Therapeutics, Inc.
- 2025
- Mar 19, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Michael Alfieri files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Todd C. Brady - $418K in ALDX purchases and sales in the last 12 months
- Richard Douglas - $98K in ALDX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Michael Alfieri?
Michael Alfieri is a corporate insider, tracked as Principal Financial Officer of Aldeyra Therapeutics, Inc. (ALDX). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Michael Alfieri last file a Form 4?
The most recent primary Form 4 on record is dated 19 March 2026, one of 2 filings going back to 2025.
Has Michael Alfieri been buying or selling stock?
Recorded transactions: 2 open-market purchases ($20K) and 0 open-market sales across all tracked filings.
